Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Consequences of Epidermal Growth Factor Receptor (ErbB1) Loss for Vascular Smooth Muscle Cells From Mice With Targeted Deletion of ErbB1
Barbara Schreier, Maria Döhler, Sindy Rabe, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2011) Vol. 31, Iss. 7, pp. 1643-1652
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Expression and Function of the Epidermal Growth Factor Receptor in Physiology and Disease
Jianchun Chen, Fenghua Zeng, Steven J. Forrester, et al.
Physiological Reviews (2016) Vol. 96, Iss. 3, pp. 1025-1069
Open Access | Times Cited: 247
Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System
Steven J. Forrester, Tatsuo Kawai, Shannon O’Brien, et al.
The Annual Review of Pharmacology and Toxicology (2015) Vol. 56, Iss. 1, pp. 627-653
Open Access | Times Cited: 150
The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease
Nader Makki, Kristina W. Thiel, Francis J. Miller
International Journal of Molecular Sciences (2013) Vol. 14, Iss. 10, pp. 20597-20613
Open Access | Times Cited: 140
Loss of Epidermal Growth Factor Receptor in Vascular Smooth Muscle Cells and Cardiomyocytes Causes Arterial Hypotension and Cardiac Hypertrophy
Barbara Schreier, Sindy Rabe, Bettina Schneider, et al.
Hypertension (2012) Vol. 61, Iss. 2, pp. 333-340
Open Access | Times Cited: 65
Role of epidermal growth factor receptor in vascular structure and function
Barbara Schreier, Michael Gekle, Claudia Großmann
Current Opinion in Nephrology & Hypertension (2014) Vol. 23, Iss. 2, pp. 113-121
Closed Access | Times Cited: 63
Advancements in understanding cardiotoxicity of EGFR- TKIs in non-small cell lung cancer treatment and beyond
Xin Li, Yongping Lin, Lin Song, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Conserved signaling mechanisms in Drosophila heart development
Shaad M. Ahmad
Developmental Dynamics (2017) Vol. 246, Iss. 9, pp. 641-656
Open Access | Times Cited: 35
Transcription-independent Induction of ERBB1 through Hypoxia-inducible Factor 2A Provides Cardioprotection during Ischemia and Reperfusion
Jae W. Lee, Michael Koeppen, Seong-Wook Seo, et al.
Anesthesiology (2019) Vol. 132, Iss. 4, pp. 763-780
Open Access | Times Cited: 34
The role of EGFR in vascular AT1R signaling: From cellular mechanisms to systemic relevance
Michael Gekle, Virginie Dubourg, Gerald Schwerdt, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115837-115837
Open Access | Times Cited: 9
Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy
Kalyan R. Chitturi, Ethan Burns, Ibrahim N. Muhsen, et al.
Current Oncology Reports (2022) Vol. 24, Iss. 4, pp. 475-491
Closed Access | Times Cited: 15
Mineralocorticoid receptor interaction with SP1 generates a new response element for pathophysiologically relevant gene expression
Sandra Meinel, Stefanie Ruhs, Katja Schumann, et al.
Nucleic Acids Research (2013) Vol. 41, Iss. 17, pp. 8045-8060
Open Access | Times Cited: 30
Deletion of the EGF receptor in vascular smooth muscle cells prevents chronic angiotensin II‐induced arterial wall stiffening and media thickening
Barbara Schreier, Mirja Hünerberg, Sigrid Mildenberger, et al.
Acta Physiologica (2017) Vol. 222, Iss. 3
Closed Access | Times Cited: 27
Substance-specific importance of EGFR for vascular smooth muscle cells motility in primary culture
Barbara Schreier, Gerald Schwerdt, Christian Heise, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2016) Vol. 1863, Iss. 7, pp. 1519-1533
Open Access | Times Cited: 19
Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action
Barbara Schreier, Mirja Hünerberg, Sindy Rabe, et al.
Clinical Science (2015) Vol. 130, Iss. 1, pp. 19-33
Closed Access | Times Cited: 18
The Functional Interaction of EGFR with AT1R or TP in Primary Vascular Smooth Muscle Cells Triggers a Synergistic Regulation of Gene Expression
Virginie Dubourg, Barbara Schreier, Gerald Schwerdt, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1936-1936
Open Access | Times Cited: 9
Novel tyrosine kinase signaling pathways
Sri Nagarjun Batchu, Vyacheslav A. Korshunov
Current Opinion in Nephrology & Hypertension (2012) Vol. 21, Iss. 2, pp. 122-127
Open Access | Times Cited: 17
Moderate inappropriately high aldosterone/NaCl constellation in mice: cardiovascular effects and the role of cardiovascular epidermal growth factor receptor
Barbara Schreier, Sindy Rabe, Sabrina De Winter, et al.
Scientific Reports (2014) Vol. 4, Iss. 1
Open Access | Times Cited: 15
Knockout of vascular smooth muscle EGF receptor in a mouse model prevents obesity-induced vascular dysfunction and renal damage in vivo
Christian Stern, Barbara Schreier, Alexander Nolze, et al.
Diabetologia (2020) Vol. 63, Iss. 10, pp. 2218-2234
Open Access | Times Cited: 13
Endothelial epidermal growth factor receptor is of minor importance for vascular and renal function and obesity-induced dysfunction in mice
Barbara Schreier, Christian Stern, Virginie Dubourg, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 12
The Roles of Integrins in Mediating the Effects of Mechanical Force and Growth Factors on Blood Vessels in Hypertension
Jun-Tzu Chao, Michael J. Davis
Current Hypertension Reports (2011) Vol. 13, Iss. 6, pp. 421-429
Closed Access | Times Cited: 14
Characterization of Type 1 Angiotensin II Receptor Activation Induced Dual-Specificity MAPK Phosphatase Gene Expression Changes in Rat Vascular Smooth Muscle Cells
Janka Borbála Gém, K Kovács, L. Szalai, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3538-3538
Open Access | Times Cited: 11
Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells
Siyu Zeng, Li Yang, Chenliang Hong, et al.
Mediators of Inflammation (2018) Vol. 2018, pp. 1-10
Open Access | Times Cited: 12
Mig-6Gene Knockout Induces Neointimal Hyperplasia in the Vascular Smooth Muscle Cell
Ju Hee Lee, Sorim Choung, Ji Min Kim, et al.
Disease Markers (2014) Vol. 2014, pp. 1-9
Open Access | Times Cited: 11
miR‑125a‑5p and miR‑7 inhibits the proliferation, migration and invasion of vascular smooth muscle cell by targeting EGFR
Hualan Zhou, Sen Lin, Youdong Hu, et al.
Molecular Medicine Reports (2021) Vol. 24, Iss. 4
Open Access | Times Cited: 8
Known players, new interplay in atherogenesis: Chronic shear stress and carbamylated-LDL induce and modulate expression of atherogenic LR11 in human coronary artery endothelium
Tarek M. Bajar, Wolfgang Winnicki, Eva-Theres Gensberger, et al.
Thrombosis and Haemostasis (2013) Vol. 112, Iss. 02, pp. 323-332
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top